OpenAlex
PricingAboutJobs
Log inGet started
Work

Opportunities and challenges using artificial intelligence in ADME/Tox

HTML

Year: 2019
Type: article
Source: Nature Materials
DOI: 10.1038/s41563-019-0332-5
Authors: Barun Bhhatarai, W. Patrick Walters, Cornelis E. C. A. Hop, Guido Lanza, Sean Ekins
Institutions: Relay Therapeutics (United States), Genentech, Collaborations Pharmaceuticals (United States)
Language: English

Topic: Computational Drug Discovery Methods
Subfield: Drug Discovery
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: artificial intelligence, machine learning, ADME-Tox, drug discovery, drug development, pharmacokinetics, drug-likeness prediction
SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of General Medical Sciences, National Center for Advancing Translational Sciences
Awards: Centralized assay datasets for modelling support of small drug discovery organizations, Biocomputation across distributed private datasets to enhance drug discovery, G9000213775
OpenAlex ID: W2935857979
FWCI: 4.754
Cites: 30
Cited by: 130
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security